Browse Drug Recalls
6,274 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 6,274 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 6,274 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Apr 18, 2017 | TRI MIX 5/30/0.5 5ML MDV MCG/MG/MG/ML INJ, Injection, 5mcg/30mg/0.5mg/mL, Rx ... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | PROGESTERONE SESAME OIL 10ML MDV 100MG/ML INJ, Injection, 100mg/mL, Rx only, ... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | FERR GLUC MDV 60MG/ML INJ, Injection, 60mg/mL, Rx only, Packaged in 5mL and 1... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | DMSO 6.25% OPHTH., 6.25%, Rx only, 15 mL plastic/Multiple Dose bottle, Prepar... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | ATROPINE SULFATE 0.5% OPHTH, Ophthalmic 0.50%, Rx only, 15mlLGlass /Multiple ... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | MAGNESIUM SO4 10ML MDV 50% INJ, Injection, 50%, Rx only, 10 mL Glass/Multiple... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 10/15/1 5ML MDV MCG/MG/MG/ML INJ, Injection, 10mcg/15mg/1mg/mL, Rx on... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | HYDROXO-B12 30ML PBF MDV (CALIF) 1MG/ML INJ, Injection, 1mg/mL, Rx only, 30 m... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | HYDROXO-B12 10ML PBF MDV 5MG/ML INJ, 5mg/mL, Rx only, 10 mL Glass/ Multiple D... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | GSH/NAC INH 2ML PV 60/100MG/ML SOLN, Inhalation Solution, 60mg/100mg/mL, Rx o... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | GSH/NAC INH PV 150/50MG/ML SOLN, Inhalation Solution, 150mg/50mg/mL, Rx only,... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 20/30/2 5ML MDV MCG/MG/MG/1ML INJ, Injection, 20mcg/30mg/2mg/mL, Rx o... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | PGE1 MDV 20MCG/ML INJ, Injection, 20mcg/mL, Rx only, packaged in a 5 mL, 10mL... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 40/30/4 5ML MDV MCG/MG/MG/ML INJ, Injection, 40mcg/30mg/4mg/mL, Rx on... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | IRON SPECIAL 5ML MDV 60/10MG/5MCG/ML INJ, Injection, 60mg/1mg/5mcg/mL, Rx onl... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | FOLIC ACID 1ML SDV 10MG/ML INJ, Injection, 10mg/mL, Rx only, 1 mL glass/Singl... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | FERR GLUC/PROCAINE 10ML MDV 60/10MG/ML INJ, Injection, 60mg/10mg/mL, Rx only,... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | CHOL/IN/ME(L)/B6 10ML MDV 50/50/25/0.1MG/ML INJ, Injection, 50mg/50mg/25mg/0... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | PAPAVERINE/PHENT 5ML MDV 30/0.5MG/ML INJ, Injection, 30/0.5mg/mL, Rx only, 5m... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | GLUTATHIONE INH *PV* 200MG/ML SOLN, Inhalation Solution, 200mg/mL, Rx only, 4... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 20/30/0.5 5ML MDV MCG/MG/MG/ML INJ, Injection, 20mcg/30mg/0.5mg/mL, R... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | PROCAINE HCL SDV 2% INJ, Injection, 2%, Rx only, packaged in 10mL and 50 mL G... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | DMPS ACID *5ML* SDV 50MG/ML INJ, Injection, 50mg/ml, Rx only, 5 mL glass/ Si... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | FOLINIC ACID MDV (CALIF) 5MG/ML INJ, Injection, 5mg/mL, Rx only, packaged in ... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 45.45/27.27/0.45 5ML MDV MCG/MG/MG/ML INJ, Injection, 45.45mcg/27.27m... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 40/30/2 5ML MDV MCG/MG/MG/ML INJ, Injection, 40mcg/30mg/2mg/mL, Rx on... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | FOLINIC ACID MDV INJ, Injection, 10 mg/mL, Rx only, packaged in 2mL and 10 mL... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | HYDROXO-B12 PBF MDV 10MG/ML INJ, Injection, 10mg/mL, Rx only, packaged in a 5... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | SODIUM BICARB 50ML MDV 8.4% (2 MOSMOL/ML) INJ, Injection, 8.40%, Rx only, 5... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | PGE1/CPZ 5ML MDV 20MCG/1MG/ML INJ, Injection, 20mcg/1mg/mL, Rx only, 5 mL Gla... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | METHYL-B12 5ML MDV (CALIF) 1MG/ML INJ, Injection, 1mg/mL, Rx only, 5 mL Glass... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 13/30/0.8 5ML MDV MCG/MG/MG/ML INJ, Injection, 13mcg/30mg/0.8mg/mL, R... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 10/30/0.5 *5ML* MDV MCG/MG/MG/ML INJ, Injection,10mcg/30mg/0.5mg/mL, ... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | CO-Q-10 OIL 20ML MDV (CALIF) 25MG/ML INJ, Injection, 25mg/mL, Rx only, 20mL... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 6/18/0.6 5ML MDV MCG/MG/MG/ML INJ, Injection, 6mcg/18mg/0.6mg/mL, Rx ... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | PGE1 5ML MDV INJ, Injection, 40mcg/mL, Rx only, 5mL glass/Multiple Dose vial... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | VIT C/GSH 1.25%-1.25% OPHTH, Ophthalmic, 1.25%, Rx only, 15 mL Plastic/ Multi... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | SODIUM CHLORIDE INH PF GV 0.9% SOLN, Inhalation Solution, 0.90%, Rx only, 5mL... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 6, 2017 | Cyanocobalamin 1 mg/mL/ Methionine 25 mg/mL/ Inositol 50 mg/mL/ Choline 50 mg... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Isomeric Pharmacy Solution, LLC |
| Apr 6, 2017 | Triamcinolone Diacetate 40 mg/mL, 10 mL Multi-Dose Vial For Injection, Rx Onl... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Isomeric Pharmacy Solution, LLC |
| Apr 6, 2017 | Testosterone Cypionate 200 mg/mL, Testosterone Propionate 20 mg/mL, 30 mL Mul... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Isomeric Pharmacy Solution, LLC |
| Apr 6, 2017 | Triamcinolone Acetonide 40 mg/mL, Lidocaine HCl 10 mg/mL , 10 mL Multi-Dose V... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Isomeric Pharmacy Solution, LLC |
| Apr 6, 2017 | Methylprednisolone Acetate 40 mg/mL, Lidocaine HCl 10 mg/mL, 10 mL Multi-Dose... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Isomeric Pharmacy Solution, LLC |
| Apr 6, 2017 | Phenylephrine 2.5%, Tropicamide 1%, 15 mL Multi-Dose Ophthalmic (spelled Opth... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Isomeric Pharmacy Solution, LLC |
| Apr 6, 2017 | Methylprednisolone Acetate 80 mg/mL, Lidocaine HCl 10 mg/mL, 10 mL Multi-Dose... | Lack of Assurance of Sterility: due to concerns with production processes which cannot assure ste... | Class II | Isomeric Pharmacy Solution, LLC |
| Mar 17, 2017 | LATANOPROST OPHTHALMIC SOLUTION, 0.005%, 125 ug/2.5 mL, packaged in 2.5 mL b... | Lack of assurance of sterility: product was found to be empty, under-filled, or leaking. | Class II | Akorn, Inc. |
| Mar 10, 2017 | Fluconazole Injection, USP, 400 mg in 200 mL, Rx only, Manufactured for: Clar... | Lack of Assurance of Sterility: there is potential of a leak from the primary container which may... | Class II | Claris Lifesciences Inc |
| Mar 10, 2017 | Levofloxacin Injection in 5% Dextrose, 750 mg in 150 mL 5% Dextrose, Rx only... | Lack of Assurance of Sterility: there is potential of a leak from the primary container which may... | Class II | Claris Lifesciences Inc |
| Mar 10, 2017 | Ciprofloxacin in Dextrose (5%) Injection, USP, 400 mg in 200 mL 5% Dextrose, ... | Lack of Assurance of Sterility: there is potential of a leak from the primary container which may... | Class II | Claris Lifesciences Inc |
| Mar 10, 2017 | Metronidazole Injection, USP, 500 mg/100 mL, Rx only, Manufactured for: Clari... | Lack of Assurance of Sterility: there is potential of a leak from the primary container which may... | Class II | Claris Lifesciences Inc |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.